ERO1α promotes hypoxic tumour progression and is associated with poor prognosis in pancreatic cancer
N. Gupta, J. E. Park, W. Tse, L. J. Kim, O. L. Kon, N. E. McCarthy, S. K. Sze
This study identifies ERO1α as a key driver of hypoxic pancreatic tumour progression and poor prognosis, supported by proteomic analysis and functional validation.
bioRxiv · Jun 6, 2019Cancer Biology